Abstract
Introduction: the ESPEN Guideline offers a multidisciplinary focus on clinical nutrition in inflammatory bowel disease (IBD). Methodology: the guideline is based on a extensive systematic review of the literature, but relies on expert opinion when objective data are lacking or inconclusive. The conclusions and 64 recommendations have been subject to full peer review and a Delphi process, in which uniformly positive responses (agree or strongly agree) were required. Results: IBD is increasingly common and potential dietary factors in its etiology are briefly reviewed. Malnutrition is highly prevalent in IBD — especially in Crohn’s disease. Increased energy and protein requirements are observed in some patients. The management of malnutrition in IBD is considered within the general context of support for malnourished patients. Treatment of iron deficiency (parenterally, if necessary) is strongly recommended. Routine provision of a special diet in IBD is not, however, supported. Parenteral nutrition is indicated only when enteral nutrition has failed or is impossible. The recommended perioperative management of patients with IBD undergoing surgery accords with general ESPEN guidance for patients having abdominal surgery. Probiotics may be helpful in UC but not in Crohn’s disease. Primary therapy using nutrition to treat IBD is not supported in ulcerative colitis but is moderately well supported in Crohn’s disease, especially in children, where the adverse consequences of steroid therapy are proportionally greater. However, exclusion diets are generally not recommended and there is little evidence to support any particular formula feed when nutritional regimens are constructed. Conclusions: available objective data to guide nutritional support and primary nutritional therapy in IBD are presented as 64 recommendations, of which 9 are very strong recommendations (grade A), 22 are strong recommendations (grade B), and 12 are based only on sparse evidence (grade 0); 21 recommendations are good practice points (GPP).
Translated title of the contribution | ESPEN Guideline: clinical nutrition in inflammatory bowel disease |
---|---|
Original language | Spanish |
Pages (from-to) | 632-653 |
Number of pages | 22 |
Journal | Nutricion Hospitalaria |
Volume | 39 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2022 |
Bibliographical note
Funding Information:El desarrollo de esta guía ha sido soportado por la ESPEN y la UEG. Su traducción al castellano ha sido llevada a cabo de manera conjunta y consensuada por miembros de la Sociedad Española de Nutrición Clínica y Metabolismo (SENPE), la Asociación Española de Gastroenterología (AEG) y la Sociedad Española de Patología Digestiva (SEPD).
Funding Information:
90. Matsui T, Sakurai T, Yao T. Nutritional therapy for Crohn’s disease in Japan. J Gastroenterol. 2005;40(Supl.16):25-31. DOI: 10.1007/BF02990575 91. Akobeng AK, Thomas AG. Enteral nutrition for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev 2007:CD005984. DOI: 10.1002/14651858.CD005984.pub2 92. Nakahigashi M, Yamamoto T, Sacco R, Hanai H, Kobayashi F. Enteral nutrition for maintaining remission in patients with quiescent Crohn’s disease: cur-rent status and future perspectives. Int J Colorectal Dis 2016;31:1-7. DOI: 10.1007/s00384-015-2348-x 93. Yamamoto T, Shiraki M, Nakahigashi M, Umegae S, Matsumoto K. Enteral nutrition to suppress postoperative Crohn’s disease recurrence: a five-year prospective cohort study. Int J Colorectal Dis 2013;28:335-40. DOI: 10.1007/ s00384-012-1587-3 94. Giannotta M, Tapete G, Emmi G, Silvestri E, Milla M. Thrombosis in inflamma-tory bowel diseases: what’s the link? Thromb J 2015;13:14. DOI: 10.1186/ s12959-015-0044-2 95. Zezos P, Kouklakis G, Saibil F. Inflammatory Bowel Disease and thrombo-embolism. World J Gastroenterol 2014;20:13863-78. DOI: 10.3748/wjg. v20.i38.13863 96. Bhakta A, Tafen M, Ahmed M, Ata A, Abraham C, Bruce D, et al. Risk of catheter-associated deep venous thrombosis in inflammatory bow-el disease. Dis Colon Rectum 2014;57:1379-83. DOI: 10.1097/ DCR.0000000000000257 97. Ha C, Magowan S, Accortt NA, Chen J, Stone CD. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009;104:1445-51. DOI: 10.1038/ajg.2009.81 98. Papay P, Miehsler W, Tilg H, Petritsch W, Reinisch W, Mayer A, et al. Clinical presentation of venous thromboembolism in inflammatory bowel disease. J Crohns Colitis 2013;7:723-9. DOI: 10.1016/j.crohns.2012.10.008 99. Yan D, Ren J, Wang G, Liu S, Li J. Predictors of response to enteral nutrition in abdominal enterocutaneous fistula patients with Crohn’s disease. Eur J Clin Nutr 2014;68:959-63. DOI: 10.1038/ejcn.2014.31 100.Visschers RG, Olde Damink SW,Winkens B, Soeters P, van Gemert WG.Treat-ment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg 2008;32:445-53. DOI: 10.1007/s00268-007-9371-1 101.Llop JM, Cobo S, Padulles A, Farran L, Jodar R, Badia MB. Nutritional sup-port and risk factors of appearance of enterocutaneous fistulas. Nutr Hosp 2012;27:213-8. DOI: 10.1590/S0212-16112012000100027 102.Dignass A, Van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Current management. J Crohn Colitis 2010;4:28-62. DOI: 10.1016/j.crohns.2009.12.002 103.Forbes A, Goldesgeyme E, Paulon E. Nutrition in inflammatory bowel disease. J Parent Ent Nutr 2011;35:571-80. DOI: 10.1177/0148607111413599 104.Mowat C, Cole A,Windsor A,Ahmad T,Arnott I, Driscoll R, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60:571-607. DOI: 10.1136/gut.2010.224154 105.Uchino M, Ikeuchi H, Matsuoka H, Matsumoto T, Takesue Y, Tomita N. Clin-ical features and management of duodenal fistula in patients with Crohn’s disease. Hepatogastroenterology 2012;59:171-4. DOI: 10.5754/hge10205 106.Triantafillidis JK, Papalois AE. The role of total parenteral nutrition in inflam-matory bowel disease: current aspects. Scand J Gastroenterol 2014;49:3-14. DOI: 10.3109/00365521.2013.860557 107.Ravindran P, Ansari N, Young CJ, Solomon MJ. Definitive surgical closure of enterocutaneous fistula: outcome and factors predictive of increased postop-erative morbidity. Colorectal Dis 2014;16:209-18. DOI: 10.1111/codi.12473 108.Akobeng AK, Thomas AG. Refeeding syndrome following exclusive enteral nutritional treatment in Crohn disease. J Pediatr Gastroenterol Nutr 2010 51:364-6. DOI: 10.1097/MPG.0b013e3181e712d6 109.Hernando A, Bretón I, Marín-Jimenez I, Menchén L. Refeeding syndrome in a patient with Crohn’s disease. J Clin Gastroenterol 2008;42:430-1. DOI: 10.1097/01.mcg.0000247989.04463.54 110.Zeljko K, Darija VB, Dina LK, Marko B. Wernicke’s encephalopathy during parenteral nutrition in a Crohn’s disease patient. Nutrition 2011;27(4):503-4. DOI: 10.1016/j.nut.2010.12.005 111.Dignass A, Lindsay JO, Sturm A, Windsor A, Colombel JF, Allez M, et al. Sec-ond European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management. J Crohn Colitis 2012;6:991-1030. DOI: 10.1016/j.crohns.2012.09.002 112.Salinas H, Dursun A, Konstantinidis I, Nguyen D, Shellito P, Hodin R, et al. Does preoperative total parenteral nutrition in patients with ulcerative coli-tis produce better outcomes? Int J Colorectal Dis 2012;27:1479-83. DOI: 10.1007/s00384-012-1535-2 113.Schwartz E. Perioperative parenteral nutrition in adults with inflammatory bowel disease: a review of the literature. Nutr Clin Pract 2016;31:159-70. DOI: 10.1177/0884533615594011 114.Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr 2017;36:623-50. DOI: 10.1016/j.clnu.2017.02.013 115.Kuppinger D, Hartl WH, Bertok M, Hoffmann JM, Cederbaum J, Küchenhoff H, et al. Nutritional screening for risk prediction in patients scheduled for abdominal operations. Br J Surg 2012;99:728-37. DOI: 10.1002/bjs.8710 116.Beattie AH, Prach AT, Baxter JP, Pennington CR.A randomised controlled trial evaluating the use of enteral nutritional supplements postoperatively in mal-nourished surgical patients. Gut 2000;46:813-8. DOI: 10.1136/gut.46.6.813 117.MacFie J,Woodcock NP, Palmer MD,Walker A,Townsend S, Mitchell CJ. Oral dietary supplements in pre-and postoperative surgical patients: a prospec-tive and randomized clinical trial. Nutrition 2000;16:723-8. DOI: 10.1016/ s0899-9007(00)00377-4 118.Espaulella J, Guyer H, Diaz-Escriu F, Mellado-Navas JA, Castells M, Pladevall M. Nutritional supplementation of elderly hip fracture patients. A randomized, double-blind, placebo-controlled trial. Age Ageing 2000;29:425-31. DOI: 10.1093/ageing/29.5.425 119.Smedley F, Bowling T, James M, Stokes E, Goodger C, O’Connor O, et al. Randomized clinical trial of the effects of preoperative and postoperative oral nutritional supplements on clinical course and cost of care. Br J Surg 2004;91:983-90. DOI: 10.1002/bjs.4578 120.Burden S, Todd C, Hill J, Lal S. Pre-operative nutrition support in patients undergoing gastrointestinal surgery. Cochrane Database Syst Rev 2012;11:CD008879. DOI: 10.1002/14651858.CD008879.pub2 121.Braga M, Gianotti L, Gentilini O, Liotta S, Di Carlo V. Feeding the gut early after digestive surgery: results of a nine-year experience. Clin Nutr 2002;21:59-65. DOI: 10.1054/clnu.2001.0504 122.Daly JM, Bonau R, Stofberg P, Bloch A, Jeevanandam M, Morse M. Imme-diate postoperative jejunostomy feeding. Clinical and metabolic results in a prospective trial. Am J Surg 1987;153:198-206. DOI: 10.1016/0002-9610(87)90815-4 123.Delany HM, Carnevale N, Garvey JW, Moss GM. Postoperative nutritional support using needle catheter feeding jejunostomy.Ann Surg 1977;186:165-70. DOI: 10.1097/00000658-197708000-00007 124.Gabor S, Renner H, Matzi V, Ratzenhofer B, Lindenmann J, Sankin O, et al. Early enteral feeding compared with parenteral nutrition after oesophageal or oesophagogastric resection and reconstruction. Br J Nutr 2005;93:509-13. DOI: 10.1079/bjn20041383 125.Gupta V. Benefits versus risks: a prospective audit. Feeding jejunostomy dur-ing esophagectomy. World J Surg 2009;33:1432-8. DOI: 10.1007/s00268-009-0019-1 126.Kemen M, Senkal M, Homann HH, Mumme A, Dauphin AK, Baier J, et al. Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact. Crit Care Med 1995;23:652-9. DOI: 10.1097/00003246-199504000-00012 127.Klein S, Kinney J, Jeejeebhoy K, Alpers D, Hellerstein M, Murray M, et al. Nutrition support in clinical practice: review of published data and recommen-dations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 1997;66:683-706. DOI: 10.1093/ajcn/66.3.683 128.Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Peri-operative total parenteral nutrition in surgical patients. N Engl J Med 1991;325:525-32. DOI: 10.1056/NEJM199108223250801 129.Bozzetti F, Gavazzi C, Miceli R, Rossi N, Mariani L, Cozzaglio L, et al. Peri-operative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. JPEN J Parenter Enteral Nutr 2000;24:7-14. DOI: 10.1177/014860710002400107 130.Shukla HS, Rao RR, Banu N, Gupta RM, Yadav RC. Enteral hyperalimentation in malnourished surgical patients. Indian J Med Res 1984;80:339-46.
Publisher Copyright:
© 2022 SENPE y Arán Ediciones S.L.